Literature DB >> 15164774

Magnetic resonance imaging of metaplastic carcinoma of the breast: sonographic and pathologic correlation.

Y W Chang1, M H Lee, K H Kwon, J H Kim, S T Park, J H Hwang, D E Goo, D L Choi, D W Lee.   

Abstract

Metaplastic carcinoma of the breast is a rare disease. We describe the MRI findings with the correlative sonographic and pathologic features of two cases. On MRI, T2-weighted images demonstrate a relatively well-defined mass with high signal intensity cystic components. Dynamic enhancement subtraction images showed an early enhancing and delayed washout peripheral rim and non-enhancing internal components. A microlobulated, isoechogenic mass with cystic components was seen sonographically, and was histopathology related to necrosis and cystic degeneration. Although these features are not unique, metaplastic carcinoma should be included in the differential diagnosis for breast masses.

Entities:  

Mesh:

Year:  2004        PMID: 15164774     DOI: 10.1080/02841850410000773

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Post-traumatic rapidly enlarging mucinous carcinoma of the breast with intratumoural haemorrhage: MRI appearances with pathological correlation.

Authors:  K Tsuji; M Goto; S Yuen; T Nishimura
Journal:  Br J Radiol       Date:  2011-06       Impact factor: 3.039

2.  Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma.

Authors:  Qing-Cong Kong; Wen-Jie Tang; Si-Yi Chen; Wen-Ke Hu; Yue Hu; Yun-Shi Liang; Qiong-Qiong Zhang; Zi-Xuan Cheng; Di Huang; Jing Yang; Yuan Guo
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

3.  Multimodality Imaging Findings of Metaplastic Breast Carcinomas: A Report of Five Cases.

Authors:  Hyun Jeong Kim; Shin Young Kim; Sun Huh
Journal:  Ultrasound Q       Date:  2018-06       Impact factor: 1.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.